Search

Your search keyword '"Warren H. Capell"' showing total 31 results

Search Constraints

Start Over You searched for: Author "Warren H. Capell" Remove constraint Author: "Warren H. Capell" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
31 results on '"Warren H. Capell"'

Search Results

1. Increased expression of the SNARE accessory protein Munc18c in lipid-mediated insulin resistance

2. Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone

Catalog

Books, media, physical & digital resources

3. Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial

4. Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD

5. Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization

6. Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial

7. Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD Trial

8. Exercise Training and Revascularization in the Management of Symptomatic Peripheral Artery Disease

9. Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization

10. Rivaroxaban in Peripheral Artery Disease after Revascularization

11. Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits

12. Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial

13. Conducting Clinical Research in Post-acute and Long-term Nursing Home Care Settings: Regulatory Challenges

14. Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization: Insights From VOYAGER PAD

15. Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study

16. Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization

17. Efficacy of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease With Venous and Prosthetic Surgical Bypass Conduits: Insights from the VOYAGER PAD Trial

18. Abstract 13474: Rivaroxaban Reduces Major Cardiovascular and Limb Events in Patients With the High-risk Triad of Chronic Kidney Disease, Peripheral Artery Disease and Recent Lower Extremity Revascularization: Insights From VOYAGER PAD

19. Abstract 14170: Reduction in Venous Thromboembolism With Rivaroxaban versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD

20. BENEFITS OF RIVAROXABAN AFTER LOWER EXTREMITY REVASCULARIZATION FOR SYMPTOMATIC PERIPHERAL ARTERY DISEASE ARE CONSISTENT WITH AND WITHOUT BACKGROUND STATIN THERAPY

21. A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization

22. EFFICACY AND SAFETY OF LOW-DOSE RIVAROXABAN IN SYMPTOMATIC PAD PATIENTS UNDERGOING REVASCULARIZATION CURRENTLY SMOKING: INSIGHTS FROM VOYAGER PAD

23. EFFICACY AND SAFETY OF RIVAROXABAN IN ELDERLY PATIENTS WITH SYMPTOMATIC PAD UNDERGOING REVASCULARIZATION: INSIGHTS FROM VOYAGER PAD

24. A Randomized Trial of Heart Failure Disease Management in Skilled Nursing Facilities (SNF Connect): Lessons Learned

25. Lack of suppression of circulating free fatty acids and hypercholesterolemia during weight loss on a high-fat, low-carbohydrate diet

26. Increased expression of the SNARE accessory protein Munc18c in lipid-mediated insulin resistance

27. Short-Term Triglyceride Lowering With Fenofibrate Improves Vasodilator Function in Subjects With Hypertriglyceridemia

28. Ethical conduct of palliative care research: enhancing communication between investigators and institutional review boards

29. Compositional Differences of LDL Particles in Normal Subjects With LDL Subclass Phenotype A and LDL Subclass Phenotype B

30. Obesity development in caspase-1-deficient mice

31. Fatty acids increase glucose uptake and metabolism in C2C12 myoblasts stably transfected with human lipoprotein lipase